Dishman Carbogen Amcis allots NCDs worth Rs 15 crore via private placement
DCAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dishman Carbogen Amcis has allotted 1,500 senior secured NCDs at face value of Rs 1 lakh each, raising Rs 15 crore through private placement at par. This is part of a larger Rs 150 crore NCD issue approved by the board in March 2026. The debentures are listed, rated, redeemable and transferable, with final maturity on 28 March 2028 (about 18 months). Coupon rate and end use of funds are not disclosed in this filing.
Adds Rs 15 crore debt to the books; part of larger Rs 150 crore NCD plan. Investors should watch for coupon rate and purpose of borrowing.